Clik here to view.
Patient Enrollment Begins for Biomarin’s Investigational Hemophilia A Gene...
BioMarin announces enrollment of the first patient in clinical trial of BMN 270, a gene therapy to treat people with hemophilia A.Read more about Patient Enrollment Begins for Biomarin’s...
View ArticleClik here to view.
FDA Approves Multiple Hemophilia A Indications for Octapharma’s NUWIQ®
FDA approves Octapharma’s latest therapy NUWIQ®, for people with hemophilia A. Clinical trial data showed good to excellent results overall.Read more about FDA Approves Multiple Hemophilia A...
View ArticleClik here to view.
New Survey Focuses on Psychosocial Issues for those Affected by Hemophilia B
Take the B-HERO-S survey and contribute to a better understanding of the psychosocial issues of living with hemophilia B.Read more about New Survey Focuses on Psychosocial Issues for those Affected...
View ArticleClik here to view.
First Person Account of NHF's Annual Meeting
Board sec'y of Hemophilia Foundation of Minnesota/Dakotas is pleasantly surprised by NHF's 67th Annual Meeting in Dallas.Read more about First Person Account of NHF's Annual MeetingLog in to post...
View ArticleClik here to view.
FDA Approves Coagadex®, First Factor X Concentrate
BPL’s new therapy offers better treatment for people with FX deficiency.Read more about FDA Approves Coagadex®, First Factor X ConcentrateLog in to post comments
View ArticleClik here to view.
Parenting Tips to Help Raise a Happy, Healthy, and Successful Child with a...
When in doubt, infuse, says a mother with real-life experience, raising a daughter with hemophilia.Read more about Parenting Tips to Help Raise a Happy, Healthy, and Successful Child with a Bleeding...
View ArticleClik here to view.
Latest Medscape Activity Looks at Role of Extended Half-Life Therapies in...
Medscape's latest online education opportunity for providers is on managing patients with hemophilia using extended half-life factor concentrates.Read more about Latest Medscape Activity Looks at Role...
View ArticleClik here to view.
Chapter on the Treatment of Hemophilia Updated in Nurses’ Guide
Latest Nurses Guide chapter focuses on factor concentrates and other treatments for patients with hemophilia A or B.Read more about Chapter on the Treatment of Hemophilia Updated in Nurses’ GuideLog...
View ArticleClik here to view.
2015 Josh Gordy Scholarship Winners
Lynden Prior and Darian Ross are the recipients of the 2015 Josh Gordy Educational Scholarship.Read more about 2015 Josh Gordy Scholarship WinnersLog in to post comments
View ArticleClik here to view.
Management of Inhibitors in Hemophilia Spotlighted in Newest Medscape Activity
Latest Medscape educational opportunity for healthcare providers is on inhibitor management.Read more about Management of Inhibitors in Hemophilia Spotlighted in Newest Medscape ActivityLog in to post...
View ArticleClik here to view.
MASAC Releases New Recommendation on Inhibitors In Light of CDC Findings
MASAC issues new recommendation on inhibitor testing and surveillance for patients with hemophilia A and B, based on CDC study findings.Read more about MASAC Releases New Recommendation on Inhibitors...
View ArticleClik here to view.
SIPPET Results to be Presented at ASH 2015
Study suggests that toddlers first treated with recombinant factor product are more likely to develop an inhibitor.Read more about SIPPET Results to be Presented at ASH 2015Log in to post comments
View ArticleClik here to view.
FDA Approves Baxalta’s Longer Lasting Therapy for Hemophilia A
FDA approves Baxalta's ADYNOVATE, a new longer- lasting recombinant factor VIII product for people with hemophilia A.Read more about FDA Approves Baxalta’s Longer Lasting Therapy for Hemophilia ALog...
View ArticleNHF Chapters Complete Winning Walk Season
NHF chapters hit the ball out of the park with a winning 2015 Walk season, raising money and awareness for the bleeding disorders community.Read more about NHF Chapters Complete Winning Walk Season
View ArticleNHF and CDC Collaborate on Screening Patients for Inhibitors
NHF and CDC work together to improve inhibitor screening and testing, after data show true prevalence among people with hemophilia.Read more about NHF and CDC Collaborate on Screening Patients for...
View ArticleClik here to view.
HTRS Announces Two Clinical Fellowship Awards Available in 2016
HTRS announces two new clinical fellowship awards in 2016 for MDs or DOs interested in focusing on hemophilia and/or other rare bleeding disorders.Read more about HTRS Announces Two Clinical...
View ArticleClik here to view.
Alnylam Announces Extension of Study for ALN-AT3
Alnylam Pharmaceuticals announces Phase 1 study of ALN-AT3, a subcutaneous therapy being tested on patients with hemophilia.Read more about Alnylam Announces Extension of Study for ALN-AT3Log in to...
View ArticleClik here to view.
Federal 340B Drug Pricing Program in the News
NHF and HTCs respond to HRSA's proposed guidance changes on 340B Drug Pricing Program.Read more about Federal 340B Drug Pricing Program in the News
View ArticleClik here to view.
NHF Chapters Complete Winning Walk Season
NHF chapters hit the ball out of the park with a winning 2015 Walk season, raising money and awareness for the bleeding disorders community.Read more about NHF Chapters Complete Winning Walk Season
View ArticleClik here to view.
NHF and CDC Collaborate on Screening Patients for Inhibitors
NHF and CDC work together to improve inhibitor screening and testing, after data show true prevalence among people with hemophilia.Read more about NHF and CDC Collaborate on Screening Patients for...
View Article